Bristol Myers Squibb Reports Third Quarter Financial Results for 2022 

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. GOOGL
6. RTX
7. COF
8. SMCI
9. TSLA
10. BRZE

Go back to Bristol Myers Squibb Reports Third Quarter Financial Results for 2022 

Bristol-Myers Squibb (BMY) Tops Q3 EPS by 17c, Beats on Revenue, Offers FY22 Revenue Guidance

October 26, 2022 3:39 AM EDT

Bristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $1.99, $0.17 better than the analyst estimate of $1.82. Revenue for the quarter came in at $11.22 billion versus the consensus estimate of $11.15 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2022 revenue of $46 billion, versus the consensus of $46... More